Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Neonatal platelet count trends during inhaled nitric oxide therapy.

Thom CS, Devine M, Kleinman S, Jensen EA, Lambert MP, Padula MA.

Br J Haematol. 2020 Feb;188(3):e28-e30. doi: 10.1111/bjh.16301. Epub 2019 Dec 15. No abstract available.

PMID:
31840227
2.

The autophagy-activating kinase ULK1 mediates clearance of free α-globin in β-thalassemia.

Lechauve C, Keith J, Khandros E, Fowler S, Mayberry K, Freiwan A, Thom CS, Delbini P, Romero EB, Zhang J, Motta I, Tillman H, Cappellini MD, Kundu M, Weiss MJ.

Sci Transl Med. 2019 Aug 21;11(506). pii: eaav4881. doi: 10.1126/scitranslmed.aav4881.

PMID:
31434755
3.

Nonspecific inhibition of erythropoiesis by short hairpin RNAs.

Traxler EA, Thom CS, Yao Y, Paralkar V, Weiss MJ.

Blood. 2018 Jun 14;131(24):2733-2736. doi: 10.1182/blood-2018-03-841304. Epub 2018 May 4. No abstract available.

4.

Utility and limitations of exome sequencing in the molecular diagnosis of pediatric inherited platelet disorders.

Romasko EJ, Devkota B, Biswas S, Jayaraman V, Rajagopalan R, Dulik MC, Thom CS, Choi J, Jairam S, Scarano MI, Krantz ID, Spinner NB, Conlin LK, Lambert MP.

Am J Hematol. 2018 Jan;93(1):8-16. doi: 10.1002/ajh.24917. Epub 2017 Oct 20.

5.

FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology.

Vo KK, Jarocha DJ, Lyde RB, Hayes V, Thom CS, Sullivan SK, French DL, Poncz M.

Blood. 2017 Jun 29;129(26):3486-3494. doi: 10.1182/blood-2017-02-770958. Epub 2017 Apr 21.

6.

Trim58 degrades Dynein and regulates terminal erythropoiesis.

Thom CS, Traxler EA, Khandros E, Nickas JM, Zhou OY, Lazarus JE, Silva AP, Prabhu D, Yao Y, Aribeana C, Fuchs SY, Mackay JP, Holzbaur EL, Weiss MJ.

Dev Cell. 2014 Sep 29;30(6):688-700. doi: 10.1016/j.devcel.2014.07.021. Epub 2014 Sep 18.

7.

Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5.

Mora-Blanco EL, Mishina Y, Tillman EJ, Cho YJ, Thom CS, Pomeroy SL, Shao W, Roberts CW.

Oncogene. 2014 Feb 13;33(7):933-8. doi: 10.1038/onc.2013.37. Epub 2013 Feb 25.

8.

Hemoglobin variants: biochemical properties and clinical correlates.

Thom CS, Dickson CF, Gell DA, Weiss MJ.

Cold Spring Harb Perspect Med. 2013 Mar 1;3(3):a011858. doi: 10.1101/cshperspect.a011858. Review.

9.

Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia.

Khandros E, Thom CS, D'Souza J, Weiss MJ.

Blood. 2012 May 31;119(22):5265-75. doi: 10.1182/blood-2011-12-397729. Epub 2012 Mar 16.

10.

TCR-dependent transformation of mature memory phenotype T cells in mice.

Wang X, Werneck MB, Wilson BG, Kim HJ, Kluk MJ, Thom CS, Wischhusen JW, Evans JA, Jesneck JL, Nguyen P, Sansam CG, Cantor H, Roberts CW.

J Clin Invest. 2011 Oct;121(10):3834-45. doi: 10.1172/JCI37210. Epub 2011 Sep 19.

11.

Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.

Wang X, Sansam CG, Thom CS, Metzger D, Evans JA, Nguyen PT, Roberts CW.

Cancer Res. 2009 Oct 15;69(20):8094-101. doi: 10.1158/0008-5472.CAN-09-0733. Epub 2009 Sep 29.

12.

Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.

McKenna ES, Sansam CG, Cho YJ, Greulich H, Evans JA, Thom CS, Moreau LA, Biegel JA, Pomeroy SL, Roberts CW.

Mol Cell Biol. 2008 Oct;28(20):6223-33. doi: 10.1128/MCB.00658-08. Epub 2008 Aug 18.

Supplemental Content

Support Center